Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Acquired by Townsquare Capital LLC

Townsquare Capital LLC grew its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 8.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 77,168 shares of the company's stock after purchasing an additional 6,249 shares during the period. Townsquare Capital LLC owned approximately 0.16% of Prestige Consumer Healthcare worth $5,564,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. BNP Paribas Financial Markets boosted its stake in shares of Prestige Consumer Healthcare by 276.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 17,379 shares of the company's stock worth $1,253,000 after purchasing an additional 12,759 shares during the period. Horizon Kinetics Asset Management LLC grew its stake in shares of Prestige Consumer Healthcare by 4.8% during the third quarter. Horizon Kinetics Asset Management LLC now owns 3,247 shares of the company's stock valued at $234,000 after buying an additional 150 shares during the last quarter. Cerity Partners LLC raised its holdings in shares of Prestige Consumer Healthcare by 103.9% in the third quarter. Cerity Partners LLC now owns 6,347 shares of the company's stock worth $458,000 after buying an additional 3,234 shares during the period. Citigroup Inc. raised its holdings in shares of Prestige Consumer Healthcare by 66.6% in the third quarter. Citigroup Inc. now owns 76,772 shares of the company's stock worth $5,535,000 after buying an additional 30,677 shares during the period. Finally, Eagle Asset Management Inc. lifted its stake in shares of Prestige Consumer Healthcare by 0.7% during the 3rd quarter. Eagle Asset Management Inc. now owns 434,514 shares of the company's stock worth $31,328,000 after acquiring an additional 3,227 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Jefferies Financial Group reiterated a "hold" rating and set a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. DA Davidson restated a "buy" rating and issued a $95.00 target price on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. One investment analyst has rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Prestige Consumer Healthcare has an average rating of "Moderate Buy" and an average price target of $83.67.

Prestige Consumer Healthcare Stock Up 0.7 %

NYSE:PBH traded up $0.60 during mid-day trading on Friday, reaching $84.77. The company's stock had a trading volume of 164,910 shares, compared to its average volume of 251,332. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $4.19 billion, a PE ratio of 20.48, a price-to-earnings-growth ratio of 2.37 and a beta of 0.47. The stock has a fifty day moving average of $75.17 and a 200-day moving average of $71.06. Prestige Consumer Healthcare Inc. has a 1 year low of $56.61 and a 1 year high of $86.36.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $1.09. The firm had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The company's quarterly revenue was down .9% on a year-over-year basis. During the same period last year, the firm earned $1.07 earnings per share. Equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider William P'pool sold 8,987 shares of the firm's stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $81.85, for a total value of $735,585.95. Following the completion of the sale, the insider now owns 20,058 shares of the company's stock, valued at $1,641,747.30. This trade represents a 30.94 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Ronald M. Lombardi sold 10,875 shares of the business's stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total value of $898,275.00. Following the transaction, the chief executive officer now owns 320,952 shares in the company, valued at approximately $26,510,635.20. This trade represents a 3.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 38,810 shares of company stock worth $3,187,300. 1.60% of the stock is owned by corporate insiders.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.